Clinical trials
Epistaxis clinical trials
Below are recruiting epistaxis clinical trials, each written for real people, not researchers. We’re tracking 7 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05281952Recruiting
Tested ways to treat severe nosebleeds after failed packing
This study looks at different management strategies for severe nosebleeds when the initial packing method has not worked for over 48 hours. It also measures the cost/benefit of these approaches to help improve care.
ToulouseAges 18 years+ - NCT06531577Recruiting
Weather and nosebleed study for Ankara residents
This study looks at whether changes in air pressure are linked to nosebleeds. It involves people living in Ankara who come to the emergency department with a nosebleed.
Ankara, YenimahalleAges 18 years+ - NCT06605989Recruiting
Which nostril is better for breathing tube placement?
This trial compares whether inserting a breathing tube through the left or right nostril causes less nosebleeds during surgery. It may help plan safer intubation for people having elective surgery.
Seoul, Dongjak-guAges 19 years+ - NCT06997796RecruitingPhase 1/Phase 2
Treating Nosebleeds in the ER with Powder Tranexamic Acid
This trial tests whether a powder form of tranexamic acid can stop nosebleeds faster in people who come to the emergency room with active bleeding. It may offer a new option if standard treatments don't work well.
Peterborough, OntarioAges 18 years+ - NCT04976036RecruitingPhase 2
Nintedanib to reduce nosebleeds in adults with HHT
This trial tests whether nintedanib can reduce how often and how severe nosebleeds are in adults with hereditary hemorrhagic telangiectasia (HHT). It may help by calming blood-vessel problems that cause bleeding.
BronAges 18 years+ - NCT06259292Recruiting
HHT patient registry tracking long-term outcomes
This registry collects health information from people with HHT over time to better understand the disease and improve care. Joining does not involve any experimental treatment, but your data will help researchers learn more about HHT.
Birmingham, AlabamaAges Any age - NCT06651255Recruiting
Algorithm-guided care for bleeding in Von Willebrand disease
This trial tests whether a special algorithm can reduce repeat bleeding from the gut or nose in people with inherited Von Willebrand disease. If you have had serious nosebleeds or digestive bleeding, this study may help find a better way to manage your condition.
Lille, NordAges 18 years+
Hear when a new Epistaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for epistaxis?
- Yes. Clin2 currently lists 7 recruiting epistaxis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a epistaxis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a epistaxis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.